(Q40248401)

18 September 2017

title

The medicinal plant goldenseal is a natural LDL-lowering agent with multiple bioactive components and new action mechanisms (English)

1 reference

18 September 2017

1 reference

Fredric B Kraemer

3

0 references

author name string

Parveen Abidi

1

1 reference

18 September 2017

Wei Chen

2

1 reference

18 September 2017

Hai Li

4

1 reference

18 September 2017

Jingwen Liu

5

1 reference

18 September 2017

publication date

2 August 2006

1 reference

Journal of Lipid Research

18 September 2017

published in

1 reference

18 September 2017

volume

47

1 reference

18 September 2017

issue

10

1 reference

18 September 2017

page(s)

2134-2147

1 reference

Pharmacotherapy for dyslipidaemia – current therapies and future agents

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600195-JLR200

An evidence-based assessment of the NCEP Adult Treatment Panel II guidelines. National Cholesterol Education Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600195-JLR200

A receptor-mediated pathway for cholesterol homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600195-JLR200

SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600195-JLR200

SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600195-JLR200

Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600195-JLR200

Metabolic interactions between mibefradil and HMG-CoA reductase inhibitors: an in vitro investigation with human liver preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600195-JLR200

Treating to target with statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600195-JLR200

Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600195-JLR200

A safety look at currently available statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600195-JLR200

A new feature on the cholesterol-lowering landscape

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600195-JLR200

Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600195-JLR200

Extracellular signal-regulated kinase-dependent stabilization of hepatic low-density lipoprotein receptor mRNA by herbal medicine berberine

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600195-JLR200

Induction of low density lipoprotein receptor (LDLR) transcription by oncostatin M is mediated by the extracellular signal-regulated kinase signaling pathway and the repeat 3 element of the LDLR promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600195-JLR200

Identification of unique lipoprotein subclasses for visceral obesity by component analysis of cholesterol profile in high-performance liquid chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600195-JLR200

Chemical comparison of goldenseal (Hydrastis canadensis L.) root powder from three commercial suppliers

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600195-JLR200

Identification of a novel sterol-independent regulatory element in the human low density lipoprotein receptor promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600195-JLR200

SCAP ligands are potent new lipid-lowering drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600195-JLR200

Synergistic activation of human LDL receptor expression by SCAP ligand and cytokine oncostatin M.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600195-JLR200

Determination of the major isosteroidal alkaloids in bulbs of Fritillaria by high-performance liquid chromatography coupled with evaporative light scattering detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600195-JLR200

Bacteria lacking a multidrug pump: a sensitive tool for drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600195-JLR200

Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5'-methoxyhydnocarpin, a multidrug pump inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600195-JLR200

Synthesis of functionalized 2-aryl-5-nitro-1H-indoles and their activity as bacterial NorA efflux pump inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600195-JLR200

Functional assessment of multiple P-glycoprotein (P-gp) probe substrates: influence of cell line and modulator concentration on P-gp activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600195-JLR200

Modulation of MDR1 gene expression in multidrug resistant MCF7 cells by low concentrations of small interfering RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600195-JLR200

P-Glycoprotein expression in human retinal pigment epithelium cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600195-JLR200

DiOC2(3) is not a substrate for multidrug resistance protein (MRP)-mediated drug efflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600195-JLR200

Interaction of dietary cholesterol and triglycerides in the regulation of hepatic low density lipoprotein transport in the hamster

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600195-JLR200

Synthesis, DNA-binding affinities, and binding mode of berberine dimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600195-JLR200

Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600195-JLR200

10.1194/JLR.M600195-JLR200

21 January 2018

Identifiers

DOI

1 reference

18 September 2017

1 reference